In vivo visualization of PARP inhibitor pharmacodynamics

BACKGROUND: [(18)F]FluorThanatrace ([(18)F]FTT) is a radiolabeled poly (adenosine diphosphate-ribose) polymerase inhibitor (PARPi) that enables noninvasive quantification of PARP with potential to serve as a biomarker for patient selection for PARPi therapy. Here we report for the first time to our...

Descripción completa

Detalles Bibliográficos
Autores principales: McDonald, Elizabeth S., Pantel, Austin R., Shah, Payal D., Farwell, Michael D., Clark, Amy S., Doot, Robert K., Pryma, Daniel A., Carlin, Sean D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2021
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119179/
https://www.ncbi.nlm.nih.gov/pubmed/33884961
http://dx.doi.org/10.1172/jci.insight.146592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119179/
https://www.ncbi.nlm.nih.gov/pubmed/33884961
http://dx.doi.org/10.1172/jci.insight.146592

Ejemplares similares